Exosens valuation
€50.00Change from previous close: −4.85%Absolute change: −€2.55
Valuation
The P/E ratio is 119.0. The average price target of 10 analysts is €69.85.
Data as of November 22, 2026
Exosens compared with similar companies
Exosens's P/E (trailing 12 months): 119.0, +197% against the median of a group of 10 similar companies (40.0).
| Metric | Exosens | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 119.0 | 40.0 | 22.1 – 72.4 | High |
| Forward P/E | 20.5 | 18.2 | 15.4 – 28.7 | Middle |
| EV/EBITDA | 26.2 | 17.6 | 13.9 – 31.3 | Middle |
| Price/book | 5.65 | 4.44 | 2.94 – 5.85 | Middle |
| Price/sales | 5.05 | 2.15 | 1.72 – 3.55 | High |
| Gross margin | 60.1% | 35.6% | 23.9% – 50.4% | High |
| Operating margin | 17.4% | 9.8% | 4.7% – 12.0% | High |
| Net margin | 6.0% | 4.9% | 3.4% – 9.0% | Middle |
| ROE | 12.7% | 10.7% | 6.5% – 15.5% | Middle |
| Debt/equity | 0.60 | 0.60 | 0.28 – 1.15 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- €2.53B
- Enterprise value
- €2.75B
- PEG
- 1.03
- EV/revenue
- 5.47
Profitability and growth
- ROA
- 6.2%
- ROIC
- 10.3%
- Revenue growth (year over year)
- 15.3%
- Earnings growth (year over year)
- -45.1%
Financial health
- Total cash
- €69.23M
- Total debt
- €269.47M
- Current ratio
- 2.35
- Quick ratio
- 1.32
- Altman Z-Score
- 4.81
- Piotroski F-Score
- 6.00
Dividends
- Payout ratio
- 71.4%
Analysts and estimates
- Average price target
- €69.85
- Median price target
- €69.50
- High price target
- €75.00
- Low price target
- €63.00
- Analysts with a price target
- 10
- Consensus
- Buy
- Forward EPS
- €2.44
- EPS estimate, current year
- €1.91
Shares and trading
- Beta
- 0.86
- Average volume
- 82.8K
- Shares outstanding
- 50.67M
- Float
- 32.83M
- Institutional ownership
- 48.7%
- Insider ownership
- 31.3%
